Varied functions of immune checkpoints during cancer metastasis

被引:0
作者
Ali Safarzadeh
Mohsen Alizadeh
Fatemeh Beyranvand
Reza Falavand Jozaaee
Khalil Hajiasgharzadeh
Amir Baghbanzadeh
Afshin Derakhshani
Antonella Argentiero
Behzad Baradaran
Nicola Silvestris
机构
[1] Tabriz University of Medical Sciences,Immunology Research Center
[2] Lorestan University of Medical Sciences,Student Research Committee
[3] IRCCS IstitutoTumori “Giovanni Paolo II” of Bari,Department of Biomedical Sciences and Human Oncology
[4] University of Bari “Aldo Moro”,undefined
来源
Cancer Immunology, Immunotherapy | 2021年 / 70卷
关键词
Immune checkpoints; Metastasis; Tumor; Immune system;
D O I
暂无
中图分类号
学科分类号
摘要
Immune checkpoints comprise diverse receptors and ligands including costimulatory and inhibitory molecules, which play monumental roles in regulating the immune system. Immune checkpoints retain key potentials in maintaining the immune system homeostasis and hindering the malignancy development and autoimmunity. The expression of inhibitory immune checkpoints delineates an increase in a plethora of metastatic tumors and the inhibition of these immune checkpoints can be followed by promising results. On the other hand, the stimulation of costimulatory immune checkpoints can restrain the metastasis originating from diverse tumors. From the review above, key findings emerged regarding potential functions of inhibitory and costimulatory immune checkpoints targeting the metastatic cascade and point towards novel potential Achilles’ heels of cancer that might be exploited therapeutically in the future.
引用
收藏
页码:569 / 588
页数:19
相关论文
共 503 条
[71]  
Yu M(2012)B7–H3 is expressed in human hepatocellular carcinoma and is associated with tumor aggressiveness and postoperative recurrence Cancer Immunol Immunother 100 4712-1241
[72]  
Lu B(2013)B7–H3 overexpression in pancreatic cancer promotes tumor progression Int J Mol Med 106 2437-10
[73]  
Liu Y(2014)Aberrant expression of B7–H3 in gastric adenocarcinoma promotes cancer cell metastasis Oncol Rep 8 7029-191
[74]  
Yan W(2011)Expression of B7–H3 in hypopharyngeal squamous cell carcinoma as a predictive indicator for tumor metastasis and prognosis Int J Oncol 36 1551-157
[75]  
Liu X(2008)CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit Proc Natl Acad Sci 6 490-6661
[76]  
Ma H(2003)Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients Proc Natl Acad Sci 107 1547-1929
[77]  
Zhang H(2006)Biologic and immunomodulatory events after CTLA-4 blockade with ticilimumab in patients with advanced malignant melanoma Cancer 12 37-4901
[78]  
Xiang R(2015)Distinct role of Tim-3 in systemic lupus erythematosus and clear cell renal cell carcinoma Int J Clin Exp Med 41 1231-2337
[79]  
Wu B(2010)Endothelial cell-expressed Tim-3 facilitates metastasis of melanoma cells by activating the NF-κB pathway Oncol Rep 69 1-1716
[80]  
Piao Y-R(2016)TIM-3 promotes the metastasis of esophageal squamous cell carcinoma by targeting epithelial-mesenchymal transition via the Akt/GSK-3β/Snail signaling pathway Oncol Rep 60 179-353